Harry Nísen

Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity

Zydrune Polianskyte-Prause, Tuomas Tolvanen, Sonja Lindfors et al. · The FASEB Journal · 2018 · 98 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo

Sonja Lindfors, Zydrune Polianskyte-Prause, Rim Bouslama et al. · Diabetologia · 2021 · 64 citations · Full text

Medicine, Nephrology, Pharmacology +17

The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery—Results from RECUR Consortium

Yasmin Abu‐Ghanem, Thomas Powles, Umberto Capitanio et al. · European Urology Oncology · 2020 · 58 citations · Full text

Medicine, Oncology, Surgery +16

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro et al. · Journal for ImmunoTherapy of Cancer · 2021 · 53 citations · Full text

Life Sciences, Immunology, Oncology +17

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by <i>ex vivo</i> drug testing of multiple patient‐derived cancer cells

Khalid Saeed, Poojitha Ojamies, Teijo Pellinen et al. · International Journal of Cancer · 2018 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17